Novel il-2 sequences and uses thereof
TW202626105APending Publication Date: 2026-07-01ASCENDIS PHARMA ONCOLOGY DIV AS
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115109647
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-03-11
- Filing Date
- 2021-06-02
- Publication Date
- 2026-07-01
Abstract
The present invention relates to an IL-2 protein sequence of the formula Ala - SEQ A - Cys* - SEQ B (I), wherein SEQ A has at least 94% sequence identity to SEQ ID NO:1; SEQ B has at least 94% sequence identity to SEQ ID NO:2; Ala is an alanine residue; and Cys* is a cysteine residue; to conjugates thereof and their uses in the treatment of cancer.
Need to check novelty before this filing date? Find Prior Art